Horas Konstantin, Fraissler Lukas, Maier Gerrit, Jakob Franz, Seefried Lothar, Konrads Christian, Rudert Maximilian, Walcher Matthias
1 Department of Orthopedics, Koenig-Ludwig-Haus, University of Wuerzburg, Wuerzburg, Germany.
2 Department of Orthopedic Surgery, Pius-Hospital, Carl-von-Ossietzky-University, Oldenburg, Germany.
Foot Ankle Int. 2017 Jul;38(7):760-766. doi: 10.1177/1071100717697427. Epub 2017 Mar 24.
Bone marrow edema syndrome (BMOS) is a phenomenon primarily affecting the lower extremity. It is characterized by a sudden onset of pain and an ill-defined osseous hyperintense signal in magnetic resonance imaging. The main cause of BMOS is still largely unknown. Its pathophysiology is presumably multifactorial and it has recently been demonstrated that it usually involves an increase in bone turnover and alterations within the bone microenvironment. Vitamin D plays a pivotal role in maintaining a healthy and well-balanced bone microenvironment. However, to date only limited information has been reported on vitamin D status in patients with BMOS. Moreover, it is still uncertain whether hypovitaminosis D is associated with the etiology and course of the disease. For this reason, the aim of this study was to determine serum vitamin D levels (25(OH)D) of patients diagnosed with BMOS of the foot and ankle.
Patients were identified and laboratory results collected by retrospective review of the medical records between year 2011 and 2015. Diagnosis was based on clinical examination, the existence of prolonged foot pain, the presence of abnormal bone marrow signal intensity in T1- and T2-weighted magnetic resonance imaging, and the patient's medical history. All patients who demonstrated other concomitant diagnoses were excluded from the study.
Overall, 31 patients were affected by BMOS with a mean age of 44.4 (range, 18-76) years. Notably, 84% of patients (26/31) had low vitamin D levels with a mean 25(OH)D level of 19.03 ng/mL. Specifically, 61% of patients (19/31) were vitamin D deficient, 23% (7/31) vitamin D insufficient, and only 5 patients (16%) had sufficient vitamin D levels. Statistical analysis showed no significant difference comparing vitamin D levels with patient age, sex, and time of diagnosis. Moreover, there was no correlation between vitamin D status and the number of bony foci or location of BMOS.
We found a widespread rate of vitamin D deficiency in patients presenting with BMOS of the foot and ankle. Comparing these data to the vitamin D status of the general population in Germany and to patients living in comparable latitudes, this raises the possibility that BMOS might be associated with low vitamin D status.
Level IV, retrospective case series.
骨髓水肿综合征(BMOS)是一种主要影响下肢的现象。其特征为突然发作的疼痛以及磁共振成像中不明确的骨质高信号。BMOS的主要病因在很大程度上仍不清楚。其病理生理学可能是多因素的,最近已证明它通常涉及骨转换增加和骨微环境内的改变。维生素D在维持健康且平衡的骨微环境中起关键作用。然而,迄今为止,关于BMOS患者维生素D状态的报道仅有有限的信息。此外,维生素D缺乏是否与该疾病的病因和病程相关仍不确定。因此,本研究的目的是确定被诊断为足踝部BMOS患者的血清维生素D水平(25(OH)D)。
通过回顾性查阅2011年至2015年的病历确定患者并收集实验室结果。诊断基于临床检查、长时间足部疼痛的存在、T1加权和T2加权磁共振成像中骨髓信号强度异常以及患者的病史。所有有其他伴随诊断的患者均被排除在研究之外。
总体而言,31例患者受BMOS影响,平均年龄为44.4岁(范围18 - 76岁)。值得注意的是,84%的患者(26/31)维生素D水平较低,平均25(OH)D水平为19.03 ng/mL。具体而言,61%的患者(19/31)维生素D缺乏,23%(7/31)维生素D不足,只有5例患者(16%)维生素D水平充足。统计分析显示,比较维生素D水平与患者年龄、性别和诊断时间无显著差异。此外,维生素D状态与骨病灶数量或BMOS位置之间无相关性。
我们发现足踝部BMOS患者中维生素D缺乏的发生率很高。将这些数据与德国普通人群以及生活在类似纬度地区患者的维生素D状态进行比较,这增加了BMOS可能与低维生素D状态相关的可能性。
IV级,回顾性病例系列。